These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 15190072)

  • 1. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation.
    Kyo S; Sada K; Qu X; Maeno K; Miah SM; Kawauchi-Kamata K; Yamamura H
    Genes Cells; 2003 Oct; 8(10):825-36. PubMed ID: 14531861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
    Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
    Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.
    Chernock RD; Cherla RP; Ganju RK
    Blood; 2001 Feb; 97(3):608-15. PubMed ID: 11157475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.
    Magnifico A; Ettenberg S; Yang C; Mariano J; Tiwari S; Fang S; Lipkowitz S; Weissman AM
    J Biol Chem; 2003 Oct; 278(44):43169-77. PubMed ID: 12907674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
    Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
    Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
    van Leeuwen JE; Paik PK; Samelson LE
    Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM; Corey SJ
    Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
    Hall AB; Jura N; DaSilva J; Jang YJ; Gong D; Bar-Sagi D
    Curr Biol; 2003 Feb; 13(4):308-14. PubMed ID: 12593796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
    Goh EL; Zhu T; Leong WY; Lobie PE
    Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop.
    Mason JM; Morrison DJ; Bassit B; Dimri M; Band H; Licht JD; Gross I
    Mol Biol Cell; 2004 May; 15(5):2176-88. PubMed ID: 15004239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
    Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
    J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A; Bellosta P; Sahni M; Basilico C
    J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
    Kassenbrock CK; Anderson SM
    J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase.
    Anderson SM; Burton EA; Koch BL
    J Biol Chem; 1997 Jan; 272(2):739-45. PubMed ID: 8995358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.
    Rubin C; Litvak V; Medvedovsky H; Zwang Y; Lev S; Yarden Y
    Curr Biol; 2003 Feb; 13(4):297-307. PubMed ID: 12593795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
    Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
    J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.